Clinical Trial Update: OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation [Phase 4]

View source ↗

Summary

Phase 4 OPTIA-AF trial update evaluating rhythm-guided antithrombotic therapy after atrial fibrillation ablation; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Snippet

Sponsor: Ewha Womans University Mokdong Hospital | Conditions: Atrial Fibrillation (AF), Coronary Artery Disease | Phase 4 | Status: NOT_YET_RECRUITING